Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Applied DNA Sciences, Inc.    APDN

APPLIED DNA SCIENCES, INC.

(APDN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Applied DNA Sciences : to Present at the Imperial Capital 2020 Security Investor Conference on December 3

11/27/2020 | 10:40am EST

Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that it is scheduled to participate virtually in the Imperial Capital 2020 Security Investor Conference on Thursday, December 3, 2020. Dr. James A. Hayward, chief executive officer, will present at 10:45 a.m. EST that day and host one-on-one meetings throughout the day.

An archived webcast will be available within 24 hours of the live presentation on the “IR Calendar” section of the Applied DNA Investor Relations page at adnas.com.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and pre-clinical nucleic acid-based therapeutic drug candidates.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common stock is listed on NASDAQ under ticker symbol ‘APDN’, and its publicly traded warrants are listed on OTC under ticker symbol ‘APPDW’.

Applied DNA is a member of the Russell Microcap® Index.


© Business Wire 2020
All news about APPLIED DNA SCIENCES, INC.
01/27APPLIED DNA SCIENCES : Amendment to Annual Report (SEC Filing - 10-K/A)
PU
01/26APPLIED DNA SCIENCES : and TruTrace Technologies™ Unveil Complete Cannabis..
BU
01/20APPLIED DNA SCIENCES INC : Change in Directors or Principal Officers, Financial ..
AQ
01/20APPLIED DNA SCIENCES : Promotes Judy Murrah to COO
PU
01/20APPLIED DNA SCIENCES : Promotes Judith Murrah to COO
MT
01/20APPLIED DNA SCIENCES : Promotes Judith Murrah to Chief Operating Officer
BU
01/19LINEA™ COVID-19 ASSAY KIT : Detection of Multiple SARS-CoV-2 Variants
PU
01/19APPLIED DNA SCIENCES : Says its COVID-19 Assay Kit Able to Detect Multiple Coron..
MT
01/19APPLIED DNA SCIENCES : Linea™ COVID-19 Assay Kit Demonstrates Effectivenes..
BU
01/15APPLIED DNA SCIENCES : SafeCircle COVID-19 Test Sees 158% Increase in Average Da..
MT
More news
Financials (USD)
Sales 2021 12,9 M - -
Net income 2021 -6,63 M - -
Net Debt 2021 - - -
P/E ratio 2021 -9,54x
Yield 2021 -
Capitalization 81,2 M 81,2 M -
Capi. / Sales 2021 6,32x
Capi. / Sales 2022 9,93x
Nbr of Employees 60
Free-Float 89,5%
Chart APPLIED DNA SCIENCES, INC.
Duration : Period :
Applied DNA Sciences, Inc. Technical Analysis Chart | APDN | US03815U3005 | MarketScreener
Technical analysis trends APPLIED DNA SCIENCES, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 14,50 $
Last Close Price 10,87 $
Spread / Highest target 38,0%
Spread / Average Target 33,4%
Spread / Lowest Target 28,8%
EPS Revisions
Managers and Directors
NameTitle
James A. Hayward Chairman, President & Chief Executive Officer
Judith Murrah Chief Operating Officer
Beth M. Jantzen Chief Financial Officer & Controller
Sanford R. Simon Independent Director
Yacov A. Shamash Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
APPLIED DNA SCIENCES, INC.113.14%81
ECOLAB INC.-4.16%59 752
SIKA AG2.44%39 562
GIVAUDAN SA-0.08%38 759
EMS-CHEMIE HOLDING AG-1.47%22 152
SYMRISE AG-3.46%17 040